{"entity":{"id":"adventris-pharmaceuticals","kind":"company","name":"Adventris Pharmaceuticals","aka":[],"tldr":"Adventris Pharmaceuticals, a Johns Hopkins spin-out, develops off-the-shelf cancer vaccines designed to raise immune responses against mutant KRAS, the driver mutation shared by pancreatic, colorectal and lung cancers, with the long-term aim of a yearly vaccine that prevents those cancers before they form. Its programmes are preclinical or early clinical.","summary":"Adventris Pharmaceuticals, a Johns Hopkins spin-out, develops off-the-shelf therapeutic and preventive cancer vaccines using a platform designed to raise strong immune responses against poorly immunogenic oncogene-derived antigens. Its first vaccine targets mutant KRAS, relevant to pancreatic, colorectal and lung cancers, and the company's stated long-term vision is annual pan-cancer vaccination. Programmes are preclinical or early clinical; no sourced financing rounds are recorded here.","asOf":"2026-09-10","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/adventris-pharmaceuticals"},{"label":"Official website","url":"https://adventris.com"}],"tags":["yc"],"related":[],"cancers":["pancreatic","colorectal","nsclc"],"sections":["immunotherapy","prevention"],"technologies":["shared-antigen-vaccine"],"targets":["kras"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Baltimore, MD","country":"US","companyType":"biotech","website":"https://adventris.com","stage":"startup","ycBatch":"W23","investors":["y-combinator"],"funding":[]},"route":"/companies/adventris-pharmaceuticals/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"technology":[{"id":"shared-antigen-vaccine","kind":"technology","name":"Off-the-shelf cancer vaccines","route":"/technologies/shared-antigen-vaccine/"}],"target":[{"id":"kras","kind":"target","name":"KRAS","route":"/targets/kras/"}],"company":[{"id":"y-combinator","kind":"company","name":"Y Combinator","route":"/companies/y-combinator/"}]}}